Glycosylation in Dermatology: Unveiling the Sugar Coating of Skin Disease
Experimental Dermatology · 2025-04 · 34 (4)
DOI: 10.1111/exd.70098 ↗At a glance
Übersichtsarbeit in Experimental Dermatology, published online on 2025-04-10. Written by Linxia Shen and 3 co-authors. Institution: Department of Dermatology, Huashan Hospital, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai Institute of Derma…. Major MEDLINE topics: Skin Diseases. Cited 9 times so far (Crossref); 123 references. Funded by: Clinical Research Plan of SHDC, Leading Talent Project of Shanghai Health Commission, Key Specialty Research Centre of Shanghai Health Commission.
Abstract (original language)
Glycosylation is a common and complex post‐translational modification (PTM) of proteins, involving the attachment of glycans under the regulation of various enzymes such as glycosyltransferases. Glycosylation facilitates the correct folding of peptide chains, modifies protein conformation and activity, enhances protein stability and influences inter‐protein interactions. N‐glycosylation and O‐glycosylation are two prevalent forms, encompassing a wide range of modifications, including sialylation, fucosylation and galactosylation. In skin tumours, abnormal glycosylation promotes tumour cell proliferation, migration, invasion and metastasis, enhances anti‐tumour immunity, and potentially affects immune checkpoint therapy. In inflammatory and autoimmune skin diseases, abnormal glycosylation in T and B lymphocyte subpopulations regulates antigen recognition, signal transduction, inflammatory factor secretion and immunoglobulin function, disrupting immune system homeostasis and impacting biologic therapy efficacy. Glycosylation correlates with the severity and activity of skin diseases, serving as a potential biomarker for diagnosis, condition assessment and prognosis determination. This review provides an overview of the role of protein glycosylation in melanoma, basal cell carcinoma, squamous cell carcinoma, psoriasis, systemic lupus erythematosus, dermatomyositis and skin aging. It analyses the biosynthetic process of glycosylation, elucidates functional changes in glycoproteins and their metabolism, and offers a theoretical basis for developing new targeted therapies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Huashan Hospital, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai Institute of Dermatology, Shanghai, China.
- Department of Dermatology, Jing'an District Central Hospital, Shanghai, China.
- National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
Funding
- Clinical Research Plan of SHDC
- Leading Talent Project of Shanghai Health Commission
- Key Specialty Research Centre of Shanghai Health Commission
- Shanghai Engineering Research Center of Hair Medicine
- National Key Research and Development Program of China
Cite
APA
Shen, L., Lin, J. M., Lin, J., & Wu, W. (2025). Glycosylation in Dermatology: Unveiling the Sugar Coating of Skin Disease. Experimental Dermatology, 34(4). https://doi.org/10.1111/exd.70098
Vancouver
Shen L, Lin JM, Lin J, Wu W. Glycosylation in Dermatology: Unveiling the Sugar Coating of Skin Disease. Experimental Dermatology. 2025;34(4). doi:10.1111/exd.70098
BibTeX
@article{Shen2025,
author = {Shen, Linxia and Lin, Jui-Ming and Lin, Jinran and Wu, Wenyu},
title = {Glycosylation in Dermatology: Unveiling the Sugar Coating of Skin Disease},
journal = {Experimental Dermatology},
year = {2025},
volume = {34},
number = {4},
doi = {10.1111/exd.70098}
}
EUVIMED